AnnouncementsBiocon collaborates with Advaxis for ADXS-HPV
All Time HighBiocon has hit an all time high of Rs 494.30 on NSE
52 Week HighBiocon has hit a 52wk high of Rs 494.00 on NSE
|Company Name||Last Price||%
|Dr Reddys Labs||2726.25||-3.59||2939.80||1786.50||46,375.93|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
Biocon is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 8,845.00 crore.The company has reported a consolidated sales of Rs 701.16 crore and a Net Profit of Rs 110.39 crore for the quarter ended Dec 2013.
The company management includes John Shaw - Vice Chairman, Bala S Manian - Director, Charles L Cooney - Director, Mary Harney - Director, Ravi Mazumdar - Director, Russell Walls - Director, Daniel M Bradbury - Additional Director.
It is listed on the BSE with a BSE Code of 532523 and the NSE with an NSE Code of BIOCON.
Its Registered office is at 20th K M, Hosur Road, Electronic City P O, Bangalore,Karnataka - 560100.
Their Registrars are Karvy Computershare Private Ltd.